BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Acerus Announces Amendments to Loan Facilities

  Acerus Pharmaceuticals Corporation today announced that it has entered into an amending agreement with First Generation Capital Inc. to increase the existing subordinated secured loan facility from US$15 million to US$25 million.

  December 13, 2021

   · 

  4 min read
• Business

  Arbutus and Qilu Pharmaceutical Enter into an Exclusive Licensing Agreement and Strategic Partnership to Develop and Commercialize AB-729 in mainland China, Hong Kong, Macau and Taiwan

  Arbutus and Qilu Pharmaceutical Enter into an Exclusive Licensing Agreement and Strategic Partnership to Develop and Commercialize AB-729 in mainland China, Hong Kong, Macau and Taiwan.

  December 13, 2021

   · 

  9 min read
• Genetown

  Stealth BioTherapeutics Provides Update On Clinical Stage Rare Disease Programs

  Promising new data showing improved dystrophin levels in animal models builds further confidence in Duchenne muscular dystrophy (DMD) development program ahead of upcoming pre-IND meeting.

  December 13, 2021

   · 

  6 min read
• Pharm Country

  TG Therapeutics Announces Data Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting

  TG Therapeutics Announces Data Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting.

  December 13, 2021

   · 

  14 min read
• Pharm Country

  Actinium Pharmaceuticals, Inc. Announces Pivotal Phase 3 SIERRA Trial at the 63rd ASH Annual Meeting

  Actinium Pharmaceuticals, Inc. today announced that positive data from the fully enrolled pivotal Phase 3 SIERRA trial of Iomab-B was presented at the 63rd American Society of Hematology Annual Meeting and Exposition (ASH) that is being held December 11 – 14, 2021.

  December 13, 2021

   · 

  11 min read
• Business

  Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®

  Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis.

  December 13, 2021

   · 

  6 min read
• Drug Development

  Galecto Announces Positive Preliminary Results for Oral Galectin-3 Inhibitor GB1211 in Part 1 of its Phase 1b/2a Liver Cirrhosis Trial

  Galecto initiates Part 2 of Phase 1b/2a trial in patients with liver cirrhosis.

  December 13, 2021

   · 

  5 min read
• Drug Development

  Celularity Presents Preclinical Data on Allogeneic Genetically Modified Natural Killer (NK) and Allogeneic CAR-NK Cell Therapy Programs at the 63rd American Society of Hematology Meeting and Exposition

  Celularity Inc. (Nasdaq: CELU) (“Celularity”) presented preclinical data on the development of its placental-derived allogeneic genetically modified NK cell therapy program (CYNK-101) and its placental-derived allogeneic CAR-NK cell therapy program (CAR19-CYNK), respectively.

  December 13, 2021

   · 

  3 min read
• Business

  Neurona Therapeutics Announces C-Suite Leadership Team

  Neurona Therapeutics today announced three promotions within its leadership team.

  December 13, 2021

   · 

  6 min read
• Genetown

  Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers

  Akoya Biosciences, Inc. today announced a collaboration to advance the discovery and validation of novel predictive biomarkers for immunotherapies.

  December 13, 2021

   · 

  3 min read